Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Durken, M von Finkenstein, FG Erttmann, R Kabisch, H Schafhausen, P Jaburg, N Loliger, C Zander, AR

Citation: N. Kroger et al., Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem celltransplantation from unrelated donors, ANN HEMATOL, 80(4), 2001, pp. 209-215

Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Kabisch, H Jaburg, N Loliger, C Krull, A Zander, AR

Citation: N. Kroger et al., Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients, BONE MAR TR, 27(4), 2001, pp. 349-354

Authors: Kroger, N Zabelina, T Kruger, W Renges, H Stute, N Schrum, J Kabisch, H Schafhausen, P Jaburg, N Loliger, C Schafer, P Hinke, A Zander, AR

Citation: N. Kroger et al., Patient cytomegalovirus seropositivity with or without reactivation is themost important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin, BR J HAEM, 113(4), 2001, pp. 1060-1071

Authors: Zander, AR Zabelina, T Kroger, N Renges, H Kruger, W Loliger, C Durken, M Stockschlader, M de Wit, M Wacker-Backhaus, G Bielack, S Jaburg, N Russmann, B Erttmann, R Kabisch, H

Citation: Ar. Zander et al., Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow, BONE MAR TR, 23(9), 1999, pp. 889-893